Compare GKOS & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | ENIC |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.6B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | ENIC |
|---|---|---|
| Price | $119.43 | $4.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $132.00 | N/A |
| AVG Volume (30 Days) | ★ 847.6K | 589.9K |
| Earning Date | 02-17-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 4.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $469,820,000.00 | ★ $3,760,459,463.00 |
| Revenue This Year | $32.39 | $112,978.43 |
| Revenue Next Year | $23.05 | $0.35 |
| P/E Ratio | ★ N/A | $108.11 |
| Revenue Growth | ★ 30.38 | N/A |
| 52 Week Low | $73.16 | $2.85 |
| 52 Week High | $161.78 | $4.51 |
| Indicator | GKOS | ENIC |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 63.32 |
| Support Level | $116.73 | $4.19 |
| Resistance Level | $128.84 | $4.41 |
| Average True Range (ATR) | 6.18 | 0.09 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 70.18 | 65.44 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.